Skip to Content

'
Qiuling Shi, MD, PhD, MSc

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Symptom Research, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Office Address

The University of Texas M. D. Anderson Cancer Center
Department of Symptom Research
1515 Holcombe Boulevard
Unit Number: 1450
Houston, TX 77030
Room Number: FCT11.5076
Phone: (713) 563-1341
Fax: (713) 745-3470

Education & Training

Degree-Granting Education

2000 The Fourth Military Medical University, Xi'an, China, PHD, Epidemiology and Biostatistics
1997 The Fourth Military Medical University, Xi'an, China, MS, Epidemiology and Biostatistics
1994 West China University of Medical Science, Chengdu, China, BMed/Medical Diploma, Preventive Medicine

Postgraduate Training

9/2005-1/2007 Hawn Postdoctoral Fellowship, Symptom Research, The University of Texas M. D. Anderson Cancer Center, Houston, TX, Dr. Charles Cleeland
9/2002-9/2005 Research Fellowship, Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, Dr. Qingyi Wei
9/2000-8/2002 Research Fellowship, Epidemiology, Natl Inst for Occupational Health & Poison Control, Chinese Cntr for Disease Control and Prevention, Beijing, China, Dr. Fengsheng He

Selected Publications

Peer-Reviewed Original Research Articles
1. Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, Mobley GM, Cleeland CS. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced non-small cell lung cancer. Cancer. In Press.
2. Sprangers MA, Sloan JA, Veenhoven R, Cleeland CS, Halyard MY, Abertnethy AP, Baas F, Barsevick AM, Bartels M, Boomsma DI, Chauhan C, Dueck AC, Frost MH, Hall P, Klepstad P, Martin NG, Miaskowski C, Mosing M, Movsas B, Van Noorden CJ, Patrick DL, Pedersen NL, Ropka ME, Shi Q, Shinozaki G, Singh JA, Yang P, Zwinderman AH. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet 12(3):301-11, 6/2009. PMID: 19456223.
3. Shi Q, Wang XS, Mendoza TR, Pandya KJ, Cleeland CS. Assessing persistent cancer pain: a comparison of current-pain ratings and pain recalled from the past week. J Pain Symptom Manage 37(2):168-74, 2/2009. e-Pub 8/2008. PMID: 18676116.
4. Wang XS, Shi Q, Williams LA, Cleeland CS, Mobley GM, Reuben JM, Lee BN, Giralt SA. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation. Cancer 113(8):2102-9, 10/2008. PMCID: PMC2633777.
5. Shi Q, Langer G, Cohen J, Cleeland CS. People in pain: How do they seek relief? J Pain 8(8):624-36, 8/2007. PMID: 17586099.
6. Wang L, Wei Q, Shi Q, Guo Z, Qiao Y, Spitz MR. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis 28(7):1430-6, 7/2007. PMID: 17341660.

Abstracts
1. Shi Q, Smith T, Mendoza T, Kaw C, Cleeland CS. Symptom burden in cancer survivors: a report from the American Cancer Society's studies of cancer survivors. American Society of Clinical Oncology 2009 Annual Meeting, Orlando FL, May 29 - June 2, 2009. J Clin Oncol 27(15 Suppl) (#9598), 5/2009.

Last updated: 9/17/2009